Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one clinical trials examined immune response to a new breast cancer vaccine by ...

Endometrial cancer — in which tumors develop in the inner lining of the uterus — is the most prevalent gynecological cancer ...

A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.

While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically engineered immune cells sometimes fail to finish the job when given as a cancer ...

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

Vitamin E and selenium are essential antioxidants that support immune function and protect against cell damage. Learn about their benefits, food sources, and supplements.

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, ImmunityBio ...

He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with ...